Synthesis and Biological Response of Size-Specific, Monodisperse Drug–Silica Nanoconjugates

Drug-containing nanoparticles (NPs) with monodisperse, controlled particle sizes are highly desirable for drug delivery. Accumulating evidence suggests that NPs with sizes less than 50 nm demonstrate superior performance in vitro and in vivo. However, it is difficult to fabricate monodisperse, drug-...

Ausführliche Beschreibung